| Literature DB >> 24707479 |
Silvia Liskova1, Miriam Petrova2, Petr Karen3, Michal Behuliak3, Josef Zicha3.
Abstract
The activation of Ca(2+)-dependent Cl(-) channels during norepinephrine-induced contraction of vascular smooth muscle was suggested to depolarize cell membrane and to increase Ca(2+) entry. Hypertension and ageing are associated with altered Ca(2+) handling including possible activation of Ca(2+)-dependent Cl(-) channels. Our study was aimed to determine Ca(2+)-dependent Cl(-) channels contribution to norepinephrine-induced contraction during hypertension and ageing. Norepinephrine-induced concentration-response curves of femoral arteries from 6- and 12-month-old spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were recorded using wire myograph. Pretreatment with Ca(2+)-dependent Cl- channel inhibitor indanyloxyacetic acid 94 [R(+)-IAA-94](IAA) attenuated norepinephrine-induced contraction in all groups, but relatively more in WKY than SHR arteries. The attenuation of norepinephrine-induced contraction after Ca(2+)-dependent Cl(-) channels blockade was partially reduced in 12-month-old WKY rats, but substantially diminished in 12-month-old SHR. IAA effect was enhanced after NO synthase inhibition but decreased by ageing. In 20-month-old WKY rats norepinephrine-induced contraction was not affected by IAA but was almost abolished after cyclooxygenase inhibition by indomethacin or niflumic acid. In conclusion, contribution of Ca(2+)-dependent Cl(-) channels to norepinephrine-induced contraction diminished with age, hypertension development, and/or NO synthesis inhibition. Ca(2+)-dependent Cl(-) channels are important for maintenance of normal vascular tone while their inactivation/closing might be a pathological mechanism.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24707479 PMCID: PMC3953470 DOI: 10.1155/2014/289361
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Blood pressure and the diameter of isolated femoral arteries in adult and aged Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR).
| Parameters | Adult WKY (6 months) | Aged WKY (12 months) | Adult SHR (6 months) | Aged SHR (12 months) |
|---|---|---|---|---|
| SBP (mm Hg) | 131 ± 3 | 134 ± 4 | 221 ± 5a | 215 ± 6c |
| MAP (mm Hg) | 109 ± 3 | 112 ± 3 | 182 ± 5a | 187 ± 4c |
| DBP (mmHg) | 91 ± 3 | 94 ± 3 | 152 ± 4a | 163 ± 4c |
| Diameter ( | 995 ± 21 | 1052 ± 20a | 843 ± 27a | 943 ± 17b,c |
Data are presented as mean ± S.E.M. SBP: systolic blood pressure; MAP: mean arterial pressure; DBP: diastolic blood pressure. Significant differences: a P < 0.05 versus adult WKY; b P < 0.05 versus adult SHR; c P < 0.05 versus aged WKY.
Figure 1Norepinephrine concentration-response curves obtained in femoral arteries of adult WKY rats (6 months old, (a)), adult SHR (6 months old, (b)), aged WKY rats (12 months old, (c)), and aged SHR (12 months old, (d)) recorded under the control conditions and after the inhibition of NO synthase (L-NNA) or Ca2+-dependent Cl− channels blockade (R(+)-IAA-94, IAA) or both (IAA + L-NNA). Data are presented as mean ± S.E.M. (for number of vessels see Table 1). Depicted curves were calculated from average values obtained at studied norepinephrine concentrations.
Pharmacodynamic parameters of norepinephrine concentration-response curves determined in individual femoral arteries isolated from adult and aged WKY and SHR which were studied under the control conditions (CONTROL), in the presence of N-nitro-L-arginine (L-NNA, NO synthase inhibitor) and in the presence of R(+)-IAA-94 (IAA, Ca2+-dependent Cl− channel blocker) as well as in the presence of IAA and L-NNA (IAA + L-NNA).
| Parameters | Adult WKY (6 months) | Aged WKY (12 months) | Adult SHR (6 months) | Aged SHR (12 months) | |
|---|---|---|---|---|---|
| CONTROL | EC50 (log mol/L) | −4.93 ± 0.09 | −5.11 ± 0.13 | −5.12 ± 0.15 | −5.43 ± 0.08 |
|
| 5.26 ± 0.84 | 5.30 ± 0.64 | 8.25 ± 0.32a | 10.41 ± 0.70b,c | |
| Slope | 3.69 ± 0.55 | 3.11 ± 0.77 | 11.27 ± 0.52a | 8.80 ± 1.10c | |
|
| |||||
| L-NNA | EC50 (log mol/L) | −5.84 ± 0.13d,e | −6.14 ± 0.07d,e | −6.17 ± 0.04d,e | −6.28 ± 0.07d,e |
|
| 10.48 ± 0.70d,e | 7.29 ± 0.30a,d,e | 11.31 ± 0.54d,e | 12.63 ± 0.78c,d,e | |
| Slope | 10.03 ± 1.60d | 9.77 ± 1.84 | 12.24 ± 0.46 | 15.71 ± 3.12 | |
|
| |||||
| IAA | EC50 (log mol/L) | −5.53 ± 0.13d | −5.79 ± 0.13d,e | −5.35 ± 0.05 | −5.48 ± 0.07 |
|
| 0.15 ± 0.05d | 0.53 ± 0.08d | 1.68 ± 0.20a,d,e | 4.66 ± 0.60b,c,d,e | |
| Slope | 2.63 ± 0.78 | 1.68 ± 0.12 | 9.50 ± 1.96 | 21.12 ± 7.04 | |
|
| |||||
| IAA + L-NNA | EC50 (log mol/L) | −5.42 ± 0.12d | −5.47 ± 0.08d | −5.28 ± 0.02 | −5.46 ± 0.07b |
|
| 0.76 ± 0.03d | 1.64 ± 0.38d | 4.21 ± 0.52a,d | 9.17 ± 0.90b,c | |
| Slope | 2.00 ± 0.77 | 6.29 ± 3.20 | 18.40 ± 4.49a | 14.03 ± 0.76 | |
Data are presented as mean ± S.E.M., the number of vessels studied under different experimental conditions is indicated in parentheses (adult WKY/aged WKY/adult SHR/aged SHR). Significant differences: a P < 0.05 versus adult WKY; b P < 0.05 versus adult SHR; c P < 0.05 versus aged WKY; d P < 0.05 versus Control; e P < 0.05 versus IAA + L-NNA.
Maximal norepinephrine-induced contraction and acetylcholine-induced relaxation of femoral arteries isolated from adult and aged WKY and SHR.
| Parameters | Adult WKY | Aged WKY | Adult SHR | Aged SHR | WKY |
|---|---|---|---|---|---|
| Norepinephrine-induced (10−4 mol/L) maximal contraction (mN/mm) | 5.26 ± 0.84 | 5.30 ± 0.64 | 8.25 ± 0.32a | 10.41 ± 0.70a,b | 6.79 ± 0.20 |
| Acetylcholine-induced (3.10−8 mol/L) relaxation (%) | 53 ± 3 | 47 ± 6 | 55 ± 4 | 37 ± 4a,b | 18 ± 4c |
| Acetylcholine-induced (3.10−8 mol/L) wall tension decrease (mN/mm) | −2.70 ± 0.36 | −2.02 ± 0.41 | −4.37 ± 0.70(a) | −4.18 ± 0.55a | −0.98 ± 0.22c |
| Acetylcholine-induced relaxation (%)* | 85 ± 4 | 82 ± 5 | 67 ± 4a | 70 ± 2 | 79 ± 2 |
| Acetylcholine-induced wall tension decrease (mN/mm)* | −4.37 ± 0.65 | −3.49 ± 0.44 | −5.30 ± 0.38 | −8.04 ± 0.84a,b | −4.70 ± 0.23 |
Data are presented as mean ± S.E.M.; a P < 0.05 versus aged-matched WKY; b P < 0.05 versus adult SHR; c P < 0.05 versus WKY; (a)represents borderline significance P < 0.08. *Maximal acetylcholine-induced relaxations were achieved in femoral arteries of WKY at the concentration 10−6 mol/L and in femoral arteries of SHR at the concentration 3.10−6 mol/L.
Pharmacodynamic parameters of norepinephrine concentration-response curves determined in individual femoral arteries isolated from 20-month-old WKY rats in the presence of R(+)-IAA-94 (IAA, Ca2+-dependent Cl− channel blocker) and indomethacin (IME, cyclooxygenase inhibitor) as well as in the presence of niflumic acid (NIFLU, cyclooxygenase inhibitor, and Cl− channel blocker).
| Parameters | Control ( | IAA ( | IME ( | NIFLU ( | |
|---|---|---|---|---|---|
| WKY | EC50 (log mol/L) | −5.22 ± 0.12 | −5.89 ± 0.10a | −4.67 ± 0.18b | −4.93 ± 0.18b |
|
| 6.79 ± 0.20 | 6.86 ± 0.26 | 1.40 ± 0.10a,b | 1.18 ± 0.06a,b | |
| Slope | 3.90 ± 0.37 | 4.49 ± 0.35 | 0.43 ± 0.10a,b | 0.63 ± 0.09a,b |
Data are presented as mean ± S.E.M.; a P < 0.05 versus control; b P < 0.05 versus IAA.
Figure 2Norepinephrine concentration-response curves obtained in femoral arteries of 20-month-old WKY rats (WKY) recorded under the control conditions and after Ca2+-dependent Cl− channels blockade (R(+)-IAA-94, IAA) or after the inhibition of cyclooxygenase (indomethacin, IME) or in the presence of niflumic acid (NIFLU). Data are presented as mean ± S.E.M. (for number of vessels see Table 4). Depicted curves were calculated from average values obtained at studied norepinephrine concentrations.